Edited by Carl F. Nathan, Weill Medical College of Cornell University, New York, NY, and approved October 5, 2020 (received for review June 30, 2020) ...
13d
Novel compound attacks tuberculosis bacteria's ATP synthase, showing promise against drug resistance
Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...
Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting bacteria that cause tuberculosis. The team have produced a compound that inhibits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback